APA (7th ed.) Citation

M, G., Z, Y., X, J., X, L., Y, D., S, Z., . . . J, Y. (2025). Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling. Nature communications, 16(1), 8642. https://doi.org/10.1038/s41467-025-63796-2

Chicago Style (17th ed.) Citation

M, Guo, et al. "Inhibition of ICAM1 Diminishes Stemness and Enhances Antitumor Immunity in Glioblastoma via β-catenin/PD-L1 Signaling." Nature Communications 16, no. 1 (2025): 8642. https://doi.org/10.1038/s41467-025-63796-2.

MLA (9th ed.) Citation

M, Guo, et al. "Inhibition of ICAM1 Diminishes Stemness and Enhances Antitumor Immunity in Glioblastoma via β-catenin/PD-L1 Signaling." Nature Communications, vol. 16, no. 1, 2025, p. 8642, https://doi.org/10.1038/s41467-025-63796-2.